ATE492815T1 - Diagnostik-biomolekül(e) - Google Patents

Diagnostik-biomolekül(e)

Info

Publication number
ATE492815T1
ATE492815T1 AT07794274T AT07794274T ATE492815T1 AT E492815 T1 ATE492815 T1 AT E492815T1 AT 07794274 T AT07794274 T AT 07794274T AT 07794274 T AT07794274 T AT 07794274T AT E492815 T1 ATE492815 T1 AT E492815T1
Authority
AT
Austria
Prior art keywords
biomolecule
diagnostic biomolecule
diagnostic
quantitating
quantification
Prior art date
Application number
AT07794274T
Other languages
English (en)
Inventor
Mahesh Arjandas Choolani
Khan Khalil Razvi Jabarullah
Loganath Annamalai
Arijit Biswas
Changqing Zhao
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Application granted granted Critical
Publication of ATE492815T1 publication Critical patent/ATE492815T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
AT07794274T 2006-09-05 2007-08-20 Diagnostik-biomolekül(e) ATE492815T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG200605961-2A SG140505A1 (en) 2006-09-05 2006-09-05 Diagnostic biomolecule(s)
PCT/SG2007/000264 WO2008030186A1 (en) 2006-09-05 2007-08-20 Diagnostic biomolecule(s)

Publications (1)

Publication Number Publication Date
ATE492815T1 true ATE492815T1 (de) 2011-01-15

Family

ID=39157516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07794274T ATE492815T1 (de) 2006-09-05 2007-08-20 Diagnostik-biomolekül(e)

Country Status (10)

Country Link
US (1) US8551712B2 (de)
EP (1) EP2074427B1 (de)
CN (1) CN101589308B (de)
AT (1) ATE492815T1 (de)
AU (1) AU2007293693C1 (de)
DE (1) DE602007011476D1 (de)
ES (1) ES2362121T3 (de)
MY (1) MY145455A (de)
SG (1) SG140505A1 (de)
WO (1) WO2008030186A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021509D0 (en) * 2010-12-20 2011-02-02 Reactivlab Ltd Assay method
ES2986436T3 (es) 2011-04-15 2024-11-11 Univ Johns Hopkins Sistema de secuenciación segura
EP2728358B1 (de) * 2011-06-29 2016-10-05 Paichai University Industry-Academic Cooperation Foundation Haptoglobin alpha-r als marker zur diagnose von lungenkrebs
ES2886507T5 (es) 2012-10-29 2024-11-15 Univ Johns Hopkins Prueba de Papanicolaou para cánceres de ovario y de endometrio
ES2805852T3 (es) * 2013-12-05 2021-02-15 Univ Leipzig Procedimiento y medio para el diagnóstico no invasivo de diabetes mellitus tipo II
US11286531B2 (en) 2015-08-11 2022-03-29 The Johns Hopkins University Assaying ovarian cyst fluid
EP3467504A4 (de) * 2016-05-27 2020-02-12 Fujifilm Wako Pure Chemical Corporation Verfahren zur bestimmung von gastrointestinalem krebs
CN111868260B (zh) 2017-08-07 2025-02-21 约翰斯霍普金斯大学 用于评估和治疗癌症的方法和材料
TWI709188B (zh) 2018-09-27 2020-11-01 財團法人工業技術研究院 基於機率融合的分類器、分類方法及分類系統
EP4103748A4 (de) 2020-02-14 2024-03-13 The Johns Hopkins University Verfahren und materialien zur beurteilung von nukleinsäuren
EP4735645A2 (de) * 2023-06-28 2026-05-06 EVBiome Verfahren zum nachweis und zur behandlung von krebs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723773D0 (en) * 1997-11-12 1998-01-07 Univ Glasgow Haptoglobin assay
US7112408B2 (en) * 2001-06-08 2006-09-26 The Brigham And Women's Hospital, Inc. Detection of ovarian cancer based upon alpha-haptoglobin levels
WO2005024054A1 (en) * 2003-09-05 2005-03-17 Royal Women's Hospital Diagnostic marker for ovarian cancer
WO2007002535A2 (en) * 2005-06-24 2007-01-04 Ciphergen Biosystems, Inc. Biomarkers for ovarian cancer

Also Published As

Publication number Publication date
ES2362121T3 (es) 2011-06-28
EP2074427B1 (de) 2010-12-22
SG140505A1 (en) 2008-03-28
WO2008030186A1 (en) 2008-03-13
DE602007011476D1 (de) 2011-02-03
WO2008030186A8 (en) 2009-07-23
AU2007293693C1 (en) 2013-11-14
MY145455A (en) 2012-02-15
US8551712B2 (en) 2013-10-08
CN101589308B (zh) 2013-11-13
EP2074427A1 (de) 2009-07-01
AU2007293693B2 (en) 2013-08-01
AU2007293693A1 (en) 2008-03-13
US20100158916A1 (en) 2010-06-24
EP2074427A4 (de) 2010-01-27
CN101589308A (zh) 2009-11-25

Similar Documents

Publication Publication Date Title
ATE492815T1 (de) Diagnostik-biomolekül(e)
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
DK1889059T3 (da) Fremgangsmåde til forbedret immunoassay
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
DK2132339T3 (da) Fremgangsmåde til detektering af en analyt i en biologisk matrix
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
EP2212700B8 (de) Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
MY157955A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
SG171630A1 (en) Protein detection reagents and methods with dyes and dextrins
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
NZ593392A (en) Biomarker for detecting bladder cancer
FR2894675B1 (fr) Distinction des meningites bacteriennes et virales
WO2006096697A3 (en) Methods for determining the bivalency of protein and antibody therapeutics
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE529745T1 (de) Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
DE602005014659D1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs
PL1991875T3 (pl) Test do wykrywania patologicznych prionów
SE0602683L (sv) Diagnostisk metod
ATE499612T1 (de) Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem
GB0802456D0 (en) Diagnostic method

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties